Abcodia Ltd - Product Pipeline Analysis, 2018 Update
[Updated: 31-10-2018]

Published by Global Data on 31st October 2018 | Ref: 1085919 | This Report Is In Stock

$750 | Single User
$1500 | Site License
$2250 | Enterprise License
$750 | Single User
$1500 | Site License
$2250 | Enterprise License

Introduction

Summary

Abcodia Ltd (Abcodia) is a clinical stage company that offers commercial development of novel, scientifically validated tests for the early detection of cancer. The company offers Roca Test, a blood test for early ovarian cancer detection. It validates and discovers biomarkers for early diagnosis and screening of cancer. Abcodia develops products for the detection of breast cancer, colorectal cancer, pancreatic cancer, lung cancer, and liver disease. The company serves diagnostic, pharmaceutical and technology companies for validation and discovery of ethical biomarkers. It collaborates with global commercial, academic and charity partners. Abcodia is headquartered in Leeds, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Abcodia Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Abcodia Ltd Company Overview 5

Abcodia Ltd Company Snapshot 5

Abcodia Ltd Pipeline Products and Ongoing Clinical Trials Overview 5

Abcodia Ltd – Pipeline Analysis Overview 7

Abcodia Ltd - Key Facts 7

Abcodia Ltd - Major Products and Services 8

Abcodia Ltd Pipeline Products by Development Stage 9

Abcodia Ltd Pipeline Products Overview 11

Biomarker Test - Liver Cancer 11

Biomarker Test - Liver Cancer Product Overview 11

Diagnostic Assay - Colorectal Cancer 12

Diagnostic Assay - Colorectal Cancer Product Overview 12

Diagnostic Assay - Haematological Cancer 13

Diagnostic Assay - Haematological Cancer Product Overview 13

Diagnostic Assay - Lung Cancer 14

Diagnostic Assay - Lung Cancer Product Overview 14

Diagnostic Assay - Oesophageal Cancer 15

Diagnostic Assay - Oesophageal Cancer Product Overview 15

Diagnostic Assay - Pancreatic Cancer 16

Diagnostic Assay - Pancreatic Cancer Product Overview 16

MCM Test - Lung Cancer 17

MCM Test - Lung Cancer Product Overview 17

Molecular Biomarker - Diabetes 18

Molecular Biomarker - Diabetes Product Overview 18

Molecular Biomarker - Osteoporosis 19

Molecular Biomarker - Osteoporosis Product Overview 19

Molecular Biomarker - Rheumatoid Arthritis 20

Molecular Biomarker - Rheumatoid Arthritis Product Overview 20

Abcodia Ltd - Key Competitors 21

Abcodia Ltd - Key Employees 22

Abcodia Ltd - Locations And Subsidiaries 23

Head Office 23

Recent Developments 24

Abcodia Ltd, Recent Developments 24

Sep 30, 2016: Abcodia Statement on the ROCA Test for Ovarian Cancer Screening in the UK 24

Jan 26, 2016: Abcodia Announces Expanded U.S. Availability of the ROCA Test for Early Ovarian Cancer Detection 24

Jan 11, 2016: Abcodia Restructures Leadership Team to Drive Commercialization of the ROCA Test 25

Dec 17, 2015: Data Published in The Lancet Suggest New Ovarian Cancer Screening Test Reduces Mortality 27

Dec 02, 2015: Abcodia Announces Initial U.S. Availability of the ROCA Test to Aid in the Early Detection of Ovarian Cancer 28

Nov 24, 2015: Abcodia Appoints Richard A. Sandberg to its Board of Directors 29

May 25, 2015: Abcodia appoints President of North America to Establish US Presence and Launch the Roca Test 29

May 18, 2015: Abcodia secures funding of £5.25 million (m) to launch the ROCA test for the early detection of ovarian cancer 30

May 12, 2015: Outstanding Results From Major Ovarian Cancer Screening Trial Shows the High Performance of ROCA, Paving the Way for Its Launch by Abcodia 31

May 05, 2015: New publication reaffirms high performance of ROCA in detecting ovarian cancer 31

Appendix 33

Methodology 33

About GlobalData 36

Contact Us 36

Disclaimer 36

Additional Details

Publisher

Global Data

Publisher Information

Reference

1085919 | GDME331313PD

Number of Pages

36

Report Format

PDF

This report is published by Global Data

Download Free Report Summary PDF

Abcodia Ltd - Product Pipeline Analysis, 2018 Update [Updated: 31-10-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.